Results 71 to 80 of about 12,698 (210)
Supplemental Figure 3- Bromocriptine improves HOMA-ir in MC4R KO mice
, 2019 Bromocriptine treatment (filled bars) led to an improved HOMA index for MC4R KO mice as compared to vehicle treated (open bars) MC4R KO mice. * p < 0.05, 1-way ANOVA with Sidak’s multiple comparison test. 2-way ANOVA with Tukey’s multiple comparison test.
Sarah Framnes-DeBoer (7206893)
core +1 more source
, 1998 We compared the efficacy and safety of ropinirole with chat of bromocriptine after 6 months of treatment in a planned interim analysis of a 3-year, double-blind, randomized, multicenter study of 335 patients with early Parkinson's disease requiring ...
Brunt, ER +5 more
core +2 more sources
Effects of bromocriptine on adenylate cyclase and phosphodiesterase activities of rat striatum
, 1978 The activity of 2-bromo-α-ergokryptine (bromocriptine) (5 mg kg−1, i.p.) on adenylate cyclase and on phosphodiesterase (PDE I-PDE II) of rat striatum, has been examined both in vitro and in vivo.
Giuseppe Pagnini +3 more
core +1 more source
Clinical efficacy of bromocriptine and the influence of serum prolactin levels on disease severity in patients with chronic plaque-type psoriasis [PDF]
, 2014 Background: Psoriasis is a T-cell mediated hyperproliferative cutaneous disease of multifactorial etiology. Prolactin (PRL) has been implicated in the pathogenesis of psoriasis and several studies have pointed to a potential therapeutic role of ...
Eid, AA, AbouKhedr, NA
core +1 more source
Deep Brain Stimulation and Pregnancy: A Case Report and Literature Review
Movement Disorders Clinical Practice, Volume 13, Issue 8, Page 2006-2009, August 2026.
Verónica Cabreira, Maria José Rosas
wiley +1 more source
Therapeutic Effects of Bromocriptine in Idiopathic Parkinsonism
, 1984 Therapeutic eκects of bromocriptine were evaluated in 16 idiopathic Parkinsonism patients. 22.5mg of bromocriptine was added to the conventional antiparkinsonian agents including L-dopa, and clinical evaluation was performed according to the ...
이문규, 민헌기, 이상복
core
Stimulation of "regulatory" dopamine receptors by bromocriptine (CB-154).
, 1978 Bromocriptine produces long-lasting hypomotility and decreases brain dihydroxyphenylacetic acid (DOPAC) in mice. These effects are obtained with doses much lower than those which produce hypermotility.
DI CHIARA, GAETANO +3 more
core +1 more source
EFFECT OF BROMOCRIPTINE IN DIABETES MELLITUS: A REVIEW [PDF]
, 2021 Bromocriptine, an antinociceptive D2 receptor agonist, is thought to reorganize an excessively heightened hypothalamic drive for higher fatty acids, plasma glucose, and tri-glycerides in insulin resistant individuals by acting on circadian neuronal ...
SARAVANAN, K. M., SUNDARAM, K. MEENAKSHI
core
MOESM3 of Repositioning of bromocriptine for treatment of acute myeloid leukemia
, 2016 Additional file 3: Figure S1. Bromocriptine was identified in the in silico screening. A. Bromocriptine molecular structure generated with JMol software. A “ball and stick” chemical structure is represented. Balls: atoms (grey, carbon; red, oxygen; blue,
Amaia Etxabe (3499364) +8 more
core +1 more source
Journal of Immunology Research, 2015 Objective. Prolactin plays an important role on the disease flare of postpartum SLE patients. 76 pregnant SLE patients were enrolled in this study to evaluate the efficacy of bromocriptine (an inhibitor of prolactin secretion) on preventing the ...
Qiu Qian +9 more
doaj +1 more source